What Happened
Kristen Parker, a surgical technician at Rose Medical Center in Denver, stole patients' fentanyl-filled syringes for her own use and replaced them with saline-filled syringes that were then used on patients.
Parker was hepatitis C-positive at the time she was hired. Over the course of her diversion scheme, she injected herself with fentanyl intended for patients and refilled the used syringes with saline before they were administered. Dozens of patients at Rose Medical Center in Denver and the Audubon Surgery Center in Colorado Springs were later confirmed infected with her strain of hepatitis C, triggering a multistate public-health investigation.
Parker pleaded guilty in federal court and, on February 24, 2010, U.S. District Court Judge Robert E. Blackburn sentenced her to 360 months (30 years) in prison — well above the 20-year term contemplated in her plea agreement — followed by three years of supervised release. She was also ordered to pay more than $500,000 in restitution to the two facilities.
What Went Wrong
A single surgical technician's syringe swaps went undetected long enough to infect dozens of patients across two facilities. Key failures included:
- Pre-employment screening did not surface or account for the technician's hepatitis C status before granting her access to injectable controlled substances.
- Syringe substitution was not caught by any process verifying that a syringe presented for patient use still contained the originally dispensed medication.
- No cluster of unusual patient outcomes was linked back to a single staff member's access pattern until after infections had already spread across two facilities.
How It Could Have Been Prevented
- Verify tamper-evident packaging and seal integrity on every injectable controlled-substance syringe immediately before patient administration.
- Screen staff with access to injectable controlled substances for bloodborne pathogen status where permitted, and restrict access to a treating provider's own patients only.
- Investigate unexplained infection clusters among patients as a potential diversion indicator, not only as an infection-control issue.
- Restrict traveling or per-diem clinical staff's controlled-substance access to what is verifiably needed for their assigned patients at each facility.
Related Guidance
- Tough Issues — High-risk scenarios with annotated SQL for analyzing dispense-to-administer gaps.
- 15 Red Flags of Drug Diversion — Behavioral and transactional indicators of diversion by clinical staff.
- Hospital Diversion Prevention Checklist — Hospital self-assessment covering surgical and procedural medication controls.
- Employee Screening & Fitness for Duty — DEA screening requirements (21 C.F.R. §1301.90) for staff with controlled substance access.